TL;DR: Is the System Failing Victims of COVID-19 Vaccine Side Effects?
The UK’s Vaccine Damage Payment Scheme (VDPS) is struggling to adequately support victims of rare but severe COVID-19 vaccine side effects, like vaccine-induced thrombosis (VITT). Outdated compensation amounts (£120,000 fixed since 2007) and bureaucratic delays leave many claimants without timely financial relief. Families impacted are advocating for fairer policies, inflation-adjusted payments, and equity in processing claims, amid concerns about eroding public trust in health programs.
• VDPS approved only 180 claims out of 16,000 filed since COVID vaccines began.
• Advocates propose systemic reforms, including broader eligibility and increased compensation.
• Ethical issues around vaccine injury support highlight gaps in the public health social contract.
As public health systems evolve to prioritize fairness, trust, and transparency, individuals must be seen and supported in their struggles. Want to find practical resources for healthier living and eating? Visit MELA AI’s website for more insights.
Recent coverage and research have intensified an already complex conversation: is the current system letting down individuals who suffered harm from COVID-19 vaccines? These vaccines, credited with saving millions of lives globally, have also been linked to rare but severe side effects like vaccine-induced thrombosis (VITT), leaving victims to navigate a maze of delayed compensation, limited support, and unheard voices.
Does the Compensation System Address the Needs of the Affected?
The UK’s Vaccine Damage Payment Scheme (VDPS), in place since 1979, was intended to compensate individuals for vaccine-related harm. While it has served thousands successfully in history, it faces criticism for being outdated in the face of the COVID-19 pandemic. The stark numbers tell the story: out of 16,000 claims filed since COVID vaccines were rolled out, only 180 awards have been made, with the majority of applications still tangled in a backlog.
The design of VDPS allows for a one-off payment of £120,000, meant to financially aid anyone sustaining at least 60% disability due to a vaccine. However, experts argue this amount hasn’t been increased since 2007, overlooking years of inflation. Adjusted for current valuations, the compensation should exceed £197,000.
“The system is too slow, has too high a threshold for proving disability, and leaves many claimants without proper recourse,” says Sarah Moore, representing a group of claimants in a class-action lawsuit in the UK.
Shifting Narratives Around Vaccine Positives and Negatives
While COVID-19 vaccinations have been undisputedly life-saving, preventing 120,000 deaths and over 250,000 hospital admissions in the UK alone by late 2021, the conversation now includes those facing the fallout of adverse events. Many injured individuals and families feel ostracized from public acknowledgment, explaining that they support vaccination programs yet struggle for their plight to be recognized.
One particularly harrowing case is that of Jane Wrigley, from Buckinghamshire. Jane, once an active woman participating in half-marathons, suffered severe brain clots linked to the AstraZeneca vaccine in March 2021. Emergency surgery saved her life, but she lost her independence and mobility. Her husband Ian Wrigley has since become her full-time carer. After over two years of waiting, their VDPS claim is still unresolved.
Why Are Legal Battles Increasing?
The systemic lag and insufficiency of flat-rate benefits have spurred legal actions. Around 50 families have chosen to sue AstraZeneca under the Consumer Protection Act, asserting they were not provided with sufficient information on risks, nor were they adequately compensated.
The UK government provided indemnity to manufacturers during the vaccine rollout efforts, which has led to peculiar legal circumstances. Claims deemed legitimate are ultimately compensated by the government, not manufacturers, leaving some to wonder whether these measures may have contributed to a slower resolution system.
How Do Experts Propose Solutions?
Professor Adam Finn, a former member of the UK’s JCVI (the vaccine advisory board), emphasizes the importance of fairness and transparency. He warns that neglecting victims of vaccine injuries may erode critical trust around public health programs.
Suggestions for improving the system include:
- Expanding Compensation Beyond VDPS: Advocates push for the incorporation of COVID vaccines into the US-style Vaccine Injury Compensation Scheme (VICP), which offers broader claim eligibility and higher awards.
- Timely Handling of Appeals: Delays worsen emotional and financial strain for claimants.
- Inflation-Indexed Payments: A review applauded calls for increasing awards to reflect modern economic conditions.
AstraZeneca’s Role and the End of Vaxzevria
By May 2024, AstraZeneca formally withdrew its Vaxzevria vaccine from the market, citing excess of newer-generation mRNA options. While regulators insist the withdrawal reflected market dynamics and not safety concerns, the optics are more complex for bereaved families and injured individuals taking legal action.
Takeaways on Social Contracts and Ethical Dilemmas
Beyond the obvious medical risks, these cases highlight a broader issue: our social contract in public health. During crises like the pandemic, societies implicitly ask individuals to take part in collective action. In return, those harmed during these efforts rightfully expect acknowledgment and justice. For instance, a delayed claim system or a fixed compensation model hardly reflects the urgency or complexity of unique, life-altering side effects.
Looking Ahead
With future pandemics likely in a deeply interconnected world, public health policies may need rewiring to prioritize both collective safety and ethical reparative measures for individuals. Meanwhile, ongoing investigations, including the UK’s January 2025 vaccine module inquiry, will undoubtedly shape how future vaccine injury systems are structured.
For those dining out in Malta while navigating health complexities, systems aligning better with flexibility and care exist in everyday contexts, too. Platforms like MELA AI, for example, make informed eating choices more accessible. In the same way, we can hope for healthcare policy to transition into being truly inclusive and supportive. Find resources for healthier lifestyles on MELA AI’s website.
Frequently Asked Questions About COVID-19 Vaccine Injuries and Compensation
How does the Vaccine Damage Payment Scheme (VDPS) work for COVID-19 vaccine injuries?
VDPS is a UK government-funded scheme providing a one-time payment of £120,000 to individuals who suffer vaccine-related injuries resulting in at least 60% disablement. However, the scheme has faced criticism after nearly 16,000 COVID-19 vaccine injury claims were filed, with only 180 awards granted so far. The high threshold for proving disability and a backlog of undecided claims have led to delays and dissatisfaction among victims. Experts suggest updating the payment amount, which hasn’t changed since 2007, to better reflect inflation and modern needs. Adjusted for inflation, the compensation value should exceed £197,000. For more details, visit NHS VDPS Information.
Are families suing vaccine manufacturers like AstraZeneca for injuries?
Yes, around 50 families are suing AstraZeneca under the UK Consumer Protection Act for severe injuries caused by the AstraZeneca vaccine. They allege insufficient warnings about risks and inadequate compensation systems. However, due to government indemnity agreements with manufacturers, validated claims are compensated by the government instead of pharmaceutical companies. This unique legal arrangement has raised concerns over slower resolutions for affected individuals. Learn about similar legal action in BBC’s Investigation.
What measures can improve the current vaccine injury compensation system?
Experts propose several reforms to improve vaccine injury compensation systems:
- Include COVID-19 vaccines in the broader Vaccine Injury Compensation Program (VICP), which offers higher awards and more eligibility.
- Index payments to inflation so that compensation remains relevant economically.
- Address the backlog by prioritizing timely handling of appeals and staffing increases.
Transparency and fairness in compensation play a crucial role in maintaining trust in public health programs, according to health advisors like Professor Adam Finn.
How has public trust been affected by delayed compensation for vaccine injuries?
Delayed compensation systems and a lack of recognition for injured individuals risk eroding public trust in vaccination programs. People affected by rare adverse events often feel excluded from public health discussions, despite their support for the general benefits of immunization campaigns. The slow response to claims has created resentment and emotional strain, adding to the ethical dilemma surrounding the social contract in health emergencies. Read more about public health impacts in the National Academies Review.
How can restaurants in Malta promote healthier eating while addressing dietary concerns?
Malta’s restaurants can embrace healthier dining by participating in platforms like MELA AI, which helps establishments highlight nutritious meals and catering flexibility. The MELA Index rates restaurants on their ability to meet health-conscious standards while offering transparency in menu ingredients. Health-focused diners and tourists can easily browse restaurants recognized for their commitment to well-being. Discover local dining options and health-focused eateries on MELA AI – Malta Restaurants Directory.
Are there international models addressing vaccine injury compensation better than VDPS?
The U.S. Vaccine Injury Compensation Program (VICP) is often seen as a better alternative to VDPS. VICP allows broader eligibility, timelier processing, and offers multi-level compensation for medical costs, lost wages, and pain/suffering. Unlike the strict one-payment model of VDPS (£120,000), VICP adapts compensation based on severity and individual circumstances. Countries looking to improve vaccine injury systems can explore similar frameworks for fairer outcomes.
How can individuals explore healthy dining options that prioritize dietary needs in Malta?
Healthy dining has become easier with platforms like MELA AI, which not only categorize restaurants by health-conscious standards but also showcase flexible menus catering to various dietary restrictions like low-carb, vegetarian, or gluten-free. Many restaurants earning the prestigious MELA sticker are known for innovative approaches to nutrition and transparency. For healthier eating choices or restaurant collaborations, visit MELA AI – Promoting Healthy Dining.
What can be learned from AstraZeneca withdrawing its vaccine from the market?
AstraZeneca’s Vaxzevria vaccine withdrawal in May 2024 was due to increasing competition with advanced mRNA vaccines, not safety concerns. However, the timing added complexity for families pursuing legal action, as perceived discontinuation of the vaccine symbolized unresolved issues for many injured claimants. This case highlights the importance of proactive resolution mechanisms so that public perception aligns with transparent safety assurances.
Why is public acknowledgment of vaccine injury victims important?
Acknowledging individuals hurt by vaccine side effects reaffirms the public health principle of collective solidarity and ethical reparative support. Failure to do so alienates a minority who represent rare consequences of mass immunization. This neglect risks undermining future public health efforts by diminishing trust and participation in vaccine rollouts. Recent debates emphasize the need for comprehensive support systems to match societal expectations for fairness in healthcare crises.
Can restaurants improve branding and visibility by joining health-conscious programs?
Absolutely. Restaurants aiming to cater to health-conscious diners can improve their branding by joining programs like MELA AI, which award establishments with a recognized platform and the MELA sticker, a mark of excellence in healthy dining. Restaurants gain higher visibility, exclusive listing opportunities, and access to market insights that align with growing trends toward nutrition-focused dining. Explore branding packages and benefits for restaurants at MELA AI – Malta Restaurants Directory for Owners.
About the Author
Violetta Bonenkamp, also known as MeanCEO, is an experienced startup founder with an impressive educational background including an MBA and four other higher education degrees. She has over 20 years of work experience across multiple countries, including 5 years as a solopreneur and serial entrepreneur. Throughout her startup experience she has applied for multiple startup grants at the EU level, in the Netherlands and Malta, and her startups received quite a few of those. She’s been living, studying and working in many countries around the globe and her extensive multicultural experience has influenced her immensely.
Violetta Bonenkamp’s expertise in CAD sector, IP protection and blockchain
Violetta Bonenkamp is recognized as a multidisciplinary expert with significant achievements in the CAD sector, intellectual property (IP) protection, and blockchain technology.
CAD Sector:
- Violetta is the CEO and co-founder of CADChain, a deep tech startup focused on developing IP management software specifically for CAD (Computer-Aided Design) data. CADChain addresses the lack of industry standards for CAD data protection and sharing, using innovative technology to secure and manage design data.
- She has led the company since its inception in 2018, overseeing R&D, PR, and business development, and driving the creation of products for platforms such as Autodesk Inventor, Blender, and SolidWorks.
- Her leadership has been instrumental in scaling CADChain from a small team to a significant player in the deeptech space, with a diverse, international team.
IP Protection:
- Violetta has built deep expertise in intellectual property, combining academic training with practical startup experience. She has taken specialized courses in IP from institutions like WIPO and the EU IPO.
- She is known for sharing actionable strategies for startup IP protection, leveraging both legal and technological approaches, and has published guides and content on this topic for the entrepreneurial community.
- Her work at CADChain directly addresses the need for robust IP protection in the engineering and design industries, integrating cybersecurity and compliance measures to safeguard digital assets.
Blockchain:
- Violetta’s entry into the blockchain sector began with the founding of CADChain, which uses blockchain as a core technology for securing and managing CAD data.
- She holds several certifications in blockchain and has participated in major hackathons and policy forums, such as the OECD Global Blockchain Policy Forum.
- Her expertise extends to applying blockchain for IP management, ensuring data integrity, traceability, and secure sharing in the CAD industry.
Violetta is a true multiple specialist who has built expertise in Linguistics, Education, Business Management, Blockchain, Entrepreneurship, Intellectual Property, Game Design, AI, SEO, Digital Marketing, cyber security and zero code automations. Her extensive educational journey includes a Master of Arts in Linguistics and Education, an Advanced Master in Linguistics from Belgium (2006-2007), an MBA from Blekinge Institute of Technology in Sweden (2006-2008), and an Erasmus Mundus joint program European Master of Higher Education from universities in Norway, Finland, and Portugal (2009).
She is the founder of Fe/male Switch, a startup game that encourages women to enter STEM fields, and also leads CADChain, and multiple other projects like the Directory of 1,000 Startup Cities with a proprietary MeanCEO Index that ranks cities for female entrepreneurs. Violetta created the “gamepreneurship” methodology, which forms the scientific basis of her startup game. She also builds a lot of SEO tools for startups. Her achievements include being named one of the top 100 women in Europe by EU Startups in 2022 and being nominated for Impact Person of the year at the Dutch Blockchain Week. She is an author with Sifted and a speaker at different Universities. Recently she published a book on Startup Idea Validation the right way: from zero to first customers and beyond, launched a Directory of 1,500+ websites for startups to list themselves in order to gain traction and build backlinks and is building MELA AI to help local restaurants in Malta get more visibility online.
For the past several years Violetta has been living between the Netherlands and Malta, while also regularly traveling to different destinations around the globe, usually due to her entrepreneurial activities. This has led her to start writing about different locations and amenities from the POV of an entrepreneur. Here’s her recent article about the best hotels in Italy to work from.
